Integra LifeSciences
IART
IART
283 hedge funds and large institutions have $3.95B invested in Integra LifeSciences in 2022 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 112 increasing their positions, 95 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.79% less ownership
Funds ownership: 89.7% → 87.92% (-1.8%)
16% less capital invested
Capital invested by funds: $4.71B → $3.95B (-$759M)
45% less call options, than puts
Call options by funds: $5.63M | Put options by funds: $10.3M
Holders
283
Holding in Top 10
1
Calls
$5.63M
Puts
$10.3M
Top Buyers
| 1 | +$19M | |
| 2 | +$15.1M | |
| 3 | +$13.4M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.8M |
| 5 |
Two Sigma Investments
New York
|
+$10.3M |
Top Sellers
| 1 | -$159M | |
| 2 | -$38.8M | |
| 3 | -$9.11M | |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$7.18M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$4.43M |